Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Equity Average (2020 - 2026)

BioScience Health Innovations has reported Equity Average over the past 7 years, most recently at $1.6 million for Q1 2026.

  • Quarterly Equity Average rose 50.76% to $1.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Mar 2026, up 50.76% year-over-year, with the annual reading at $1.2 million for FY2025, 179.13% up from the prior year.
  • Equity Average was $1.6 million for Q1 2026 at BioScience Health Innovations, down from $1.6 million in the prior quarter.
  • Over five years, Equity Average peaked at $1.7 million in Q3 2025 and troughed at -$71621.0 in Q2 2023.
  • The 5-year median for Equity Average is $64355.5 (2022), against an average of $501182.7.
  • Year-over-year, Equity Average crashed 33.91% in 2022 and then surged 65346.42% in 2024.
  • A 5-year view of Equity Average shows it stood at $19934.5 in 2022, then tumbled by 95.38% to $921.0 in 2023, then surged by 65346.42% to $602761.5 in 2024, then surged by 164.47% to $1.6 million in 2025, then fell by 0.83% to $1.6 million in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Equity Average are $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025).